Seven days treatment with the angiotensin II type 2 receptor agonist C21 in hospitalized COVID-19 patients; a placebo-controlled randomised multi-centre double-blind phase 2 trial

por Tornling, Göran, Batta, Rohit, Porter, Joanna C., Williams, Bryan, Bengtsson, Thomas, Parmar, Kartikeya, Kashiva, Reema, Hallberg, Anders, Cohrt, Anne Katrine, Westergaard, Kate, Dalsgaard, Carl-Johan, Raud, Johan
Publicado 2021